Drug-labels.com

Solifenacin Succinate: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
5 mg, 10 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Solifenacin Succinate

ABOUT THIS MEDICATION

What the medication is used for:

Solifenacin succinate is used in the treatment of overactive bladder in adults with symptoms of frequent and urgent need to urinate (urinary frequency, urinary urgency) with urine leakage (urge urinary incontinence).

What it does:

Solifenacin succinate is a urinary antispasmodic medication that helps to relax the smooth muscle of the bladder which leads to reduction of the symptoms caused by overactive bladder.

When it should not be used:

You should not take solifenacin succinate:

  • If you are not able to empty your bladder (also called urinary retention).
  • If you have End-Stage Kidney Disease and require dialysis.
  • If you are not able to empty your stomach (also called gastroparesis).
  • If you have narrow-angle glaucoma (high pressure and pain in the eyes).
  • If you are allergic to solifenacin succinate or any of the other ingredients in solifenacin succinate tablets. See ‘What the non-medicinal ingredients are’

What the medicinal ingredient is:

The medicinal ingredient in solifenacin succinate tablet is ‘solifenacin succinate’.

What the non-medicinal ingredients are:

Each solifenacin succinate tablet contains the following inert ingredients: lactose monohydrate, maize starch, hypromellose, magnesium stearate.

Coating: hypromellose, talc, polyethylene glycol and titanium dioxide with yellow ferric oxide (5 mg and 10 mg solifenacin succinate tablets) and red ferric oxide (10 mg solifenacin succinate tablets).

What dosage form it comes in:

Solifenacin succinate is available in 5 and 10 mg tablets.

WARNINGS AND PRECAUTIONS

Before you use solifenacin succinate, talk to your doctor or pharmacist if you:

  • Have stomach problems affecting passage and digestion of food, or severe constipation.
  • Have glaucoma.
  • Have difficulty urinating, or weak urine stream.
  • Have heart disease.
  • Have a rare heart problem called QT/QTc prolongation or family history of QT/QTc prolongation.
  • Have kidney or liver problems.
  • Have reduced ability to sweat.
  • Are pregnant or planning to become pregnant. Women who might get pregnant should use an effective birth control method while taking solifenacin succinate.

  • Are breast feeding or plan to breast feed.

Solifenacin succinate should not be given to children or adolescents.

Solifenacin succinate may cause blurred vision and drowsiness. Do not drive a car, or operate any machinery, or engage in any activities that require accurate vision and full attention.

In hot weather, solifenacin succinate can cause heat prostration (fever and heat stroke due to decreased sweating). Do not stay long in a hot environment while taking the drug. If you have any symptoms of heat prostration, keep yourself cool and drink a lot of water.

Angioedema (the symptoms include swelling of the face or tongue, difficulty breathing) and anaphylactic reactions (the symptoms include hives, difficulty breathing, abdominal cramps, rapid heartbeat and feeling faint), which could be life-threatening, have been reported in some patients taking solifenacin succinate. If you experience any of these symptoms, stop taking solifenacin succinate and see your doctor immediately.

INTERACTIONS WITH THIS MEDICATION

Before and while taking solifenacin succinate you should tell your doctor about your other medications, even the medicine you bought without prescription, including vitamins and herbal supplements.

Solifenacin succinate is known to have drug interactions with the following drugs: Drug known to prolong the QT/QTc interval and/or cause torsade de pointes, drugs that decrease electrolyte levels, ancholinergic drugs, drugs that stimulate the motility of the gut such as metoclopramide, ketoconazole, clarithromycin, erythromycin, diclofenac, nefazodone, verapamil.

Drinking grapefruit juice with solifenacin succinate may increase your blood level of solifenacin.

PROPER USE OF THIS MEDICATION

Usual Dose:

5 mg daily. The daily dose may be increased to 10 mg following consultation with your doctor. Swallow the tablet whole with water.

Solifenacin succinate tablets can be taken with or without food.

Overdose:

If you think you have taken too much Solifenacin succinate, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If a dose is missed, the next tablet should be taken as planned. Doses should not be doubled to make up for a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The following side effects have been reported in clinical trials with solifenacin succinate:

Most common side effects: dry mouth and constipation

Common side effects: dry eyes, urinary retention, blurred vision, nausea, abdominal pain, indigestion, urinary tract infection.

The following side effects have been reported with the use of solifenacin succinate in worldwide post-marketing experience, although the frequency of events or a causal relationship with solifenacin succinate could not always be confirmed:

acid reflux, change in sense of taste, , decreased appetite, delirium, dizziness, dry skin, fast or irregular heartbeat, feeling sleepy, glaucoma, hallucination, headache, high potassium levels, hypersensitivity reactions, intestinal blockage, itchiness, kidney ailment, liver problems, muscle weakness, nasal dryness, voice disorder, severe skin scaling and redness, itching (exfoliative dermatitis), severe skin rash, itchiness and fever (erythema multiforme), swelling in the lower limbs and vomiting.

Tell your doctor or pharmacist if you have any side effects while taking solifenacin succinate. This includes any side effects not listed above.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY

HAPPEN AND WHAT TO DO ABOUT THEM

Symptom/effect

Talk with your

doctor or pharmacist

Stop taking

drug and call your doctor

or pharmacist

Only if

severe

In all

cases

RareAbdominal pain√

Constipation for

more than 3 days

√
Urinary retention√

Very

rare

Swelling of the

face or tongue,

difficulty breathing

√

Fast or irregular

heartbeat

√

Anaphylactic

reactions (severe

allergic reactions)

√

HOW TO STORE IT

Keep solifenacin succinate tablets and all other medications out of the reach of children.

Store between 15°C – 30°C.

Do not keep medicine that is out of date or that you no longer need.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document, plus the full product monograph prepared for health professionals, can be obtained by contacting the distributor, Jamp Pharma Corporation at 1 866 399-9091 ext. 252.

or by email, at: pv@jamppharma.com

Manufactured by:

Jubilant Generics Limited

Roorkee - 247661, India.

Distributor:

Jamp Pharma Corporation,

1310 rue Nobel ,

Boucherville, Quebec, Canada, J4B 5H3

Date of Revision: March 25, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02403595

Revision date stated in the text: March 25, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Solifenacin Succinate

Rx or OTC
Prescription (Rx)?
DIN 02403595, 02403609
Schedule(s) PRESCRIPTION
Active ingredient(s) Solifenacin succinate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD08 Solifenacin
Company JUBILANT GENERICS LIMITED
Current status Approved
Current status date December 29, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02403595 5 MG Tablet Approved December 29, 2015
02403609 10 MG Tablet Approved December 29, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.